cyclosporine and Ovarian Neoplasms

cyclosporine has been researched along with Ovarian Neoplasms in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (55.56)	18.2507
2000's	5 (18.52)	29.6817
2010's	6 (22.22)	24.3611
2020's	1 (3.70)	2.80

Authors

Authors	Studies
Besterman, JM; Chai, HB; Chávez, D; Cordell, GA; Cui, B; Farnsworth, NR; Kinghorn, AD; Lewis, JA; Lynn, SM; Monks, A; O'Neill, MJ; Pezzuto, JM; Rasoanaivo, P; Silva, GL; You, M	1
Wang, H; Wang, X; Yang, D; Zhang, R	1
Andersson, Y; Bideli, H; Flatmark, K; Fodstad, O; Wiiger, MT	1
He, H; Huang, H; Yu, T	1
Alexander, B; Rout, P; Satish, R	1
He, H; Ren, X; Yang, Y; Yu, T; Zhang, J	1
Goda, K; Kárpáti, L; Kertész, I; Krasznai, Z; Krasznai, ZT; Márián, T; Máté, G; Szabó Judit, P; Szalóki, G; Trencsényi, G	1
Fodor, Z; Galuska, L; Goda, K; Hernádi, Z; Krasznai, ZT; Mikecz, P; Szabó, G; Tóth, A	1
Chamson-Reig, A; Libertun, C; Lux-Lantos, V; Schillaci, R; Sorianello, E	1
Contag, CH; Kornacker, M; Negrin, RS; Scheffold, C; Scheffold, YC	1
Carroll, M; Chow, W; Doroshow, JH; Gandara, D; Leong, L; Longmate, J; Margolin, K; McGonigle, K; Morgan, RJ; Muggia, F; Raschko, J; Reed, E; Scudder, S; Shibata, S; Somlo, G; Synold, TW; Tetef, M; Vasilev, S; Yen, Y	1
Bernasconi, S; Celli, N; Cuevas, C; D'Incalci, M; Erba, E; Faircloth, GT; Jimeno, J; Tognon, G	1
Naito, M; Nishioka, Y; Ogura, T; Sone, S; Tsuruo, T; Yano, S	1
Ahn, C; Akman, S; Carroll, M; Doroshow, JH; Leong, L; Margolin, K; Morgan, RJ; Raschko, J; Scanlon, K; Somlo, G	1
Bergh, J; Csoka, K; Fridborg, H; Jonsson, B; Kristensen, J; Nilsson, K; Nygren, P; Oberg, G; Olsen, L; Tholander, B	1
Berman, ML; Boyle, J; DiSaia, PJ; Lentz, S; Liao, SY; Manetta, A; Mutch, D; Slater, L	1
Guinee, DG; Houghton, DC; van Zee, B	1
Chen, H; Yang, Q; Zhou, Y	1
Baumgart, J; Harstrick, A; Scheulen, ME; Schleucher, N; Schroeder, J; Seeber, S; Vanhoefer, U; Wilke, H	1
Chambers, JT; Chambers, SK; Davis, CA; Handschumacher, RE; Kohorn, EI; Lorber, MI; Pizzorno, G; Schwartz, PE	1
Blessing, JA; Hurteau, JA; Manetta, A	1
Lang, J; Shen, K; Zhu, L	1
Chambers, JT; Chambers, SK; Davis, CA; Kohorn, EI; Schwartz, PE	1
Chambers, JT; Chambers, SK; Davis, CA; Hschumacher, RE; Lorber, MI; Schwartz, PE	1
Anderson, B; Buller, RE; Skilling, JS; Sood, AK; Sorosky, JI; Squatrito, RC	1
Chen, CA; Collins, JL; Herzog, TJ; Mutch, DG	1
Nishida, T; Oda, T; Sugiyama, T; Ushijima, K; Yakushiji, M	1

Trials

7 trial(s) available for cyclosporine and Ovarian Neoplasms

Article	Year
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclosporine; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay	2004
Phase I trial of carboplatin and infusional cyclosporin in advanced malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Cyclosporine; Drug Resistance; Feasibility Studies; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Thrombocytopenia; Tumor Cells, Cultured	1995
Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study. Cancer, 1994, Jan-01, Volume: 73, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cyclosporine; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Synergism; Drug Tolerance; Female; Genital Neoplasms, Female; Humans; Kidney; Ovarian Neoplasms; Remission Induction	1994
Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cyclosporine; Feasibility Studies; Female; Germinoma; Half-Life; Humans; Immunosuppressive Agents; Mixed Tumor, Mesodermal; Ovarian Neoplasms; Pilot Projects; Retroperitoneal Space; ROC Curve	1997
Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group. Gynecologic oncology, 1998, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Cisplatin; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Ovarian Neoplasms	1998
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study. Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Cyclosporine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Fallopian Tube Neoplasms; Female; Humans; Hypertension; Immunosuppressive Agents; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Treatment Outcome	1996
Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:10 Topics: Anemia; Antineoplastic Agents; Area Under Curve; Carboplatin; Cyclosporine; Female; Humans; Hypertension; Hypotension; Immunosuppressive Agents; Infusions, Intravenous; Leukopenia; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Treatment Outcome; Vomiting	1996

Other Studies

20 other study(ies) available for cyclosporine and Ovarian Neoplasms

Article	Year
Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei. Journal of natural products, 2001, Volume: 64, Issue:12 Topics: Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Crystallography, X-Ray; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Erythroxylaceae; Esters; Female; Humans; Madagascar; Medicine, Traditional; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Roots; Plants, Medicinal; Spectrophotometry, Infrared; Stereoisomerism; Tropanes; Tumor Cells, Cultured	2001
Discrimination of Multidrug Resistance in Cancer Cells Achieved Using Single-Cell Analysis. Methods in molecular biology (Clifton, N.J.), 2023, Volume: 2689 Topics: Biological Transport; Coloring Agents; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Ovarian Neoplasms; Single-Cell Analysis	2023
The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells. Journal of ovarian research, 2014, Feb-15, Volume: 7 Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclosporine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoconjugates; Immunotoxins; Inhibitory Concentration 50; Kisspeptins; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Polymerase Chain Reaction; Receptors, Steroid; Receptors, Thyroid Hormone; Time Factors; Up-Regulation	2014
Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay. International journal of radiation biology, 2014, Volume: 90, Issue:10 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Comet Assay; Cyclosporine; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Electroporation; Female; Humans; Ovarian Neoplasms; Sonication; Treatment Outcome	2014
Double primary carcinoma in a renal allograft recipient. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:6 Topics: Allografts; Azathioprine; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Prednisolone; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2014
Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2015, Volume: 91 Topics: Animals; Antineoplastic Agents; Biological Transport; Biotransformation; Cell Line, Tumor; Cell Survival; Cisplatin; Combined Modality Therapy; Cyclosporine; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Immunosuppressive Agents; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Random Allocation; Survival Analysis; Tumor Burden; Ultrasonic Therapy; Ultrasonic Waves; Xenograft Model Antitumor Assays	2015
2'[(18)F]-fluoroethylrhodamine B is a promising radiotracer to measure P-glycoprotein function. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Jul-10, Volume: 74 Topics: Absorption, Physiological; Animals; ATP Binding Cassette Transporter, Subfamily B; Carcinoma; Cell Line, Tumor; Cyclosporine; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Fluorine Radioisotopes; Humans; Immunosuppressive Agents; Membrane Potential, Mitochondrial; Mice; Neoplasm Proteins; NIH 3T3 Cells; Ovarian Neoplasms; Proton Ionophores; Radioactive Tracers; Recombinant Proteins; Rhodamine 123; Rhodamines; Uterine Cervical Neoplasms	2015
Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Dec-23, Volume: 41, Issue:5 Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ovarian Neoplasms; Paclitaxel; Protein Binding; Rhodamine 123; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured	2010
Actions of immunosuppressor drugs on the development of an experimental ovarian tumor. Experimental biology and medicine (Maywood, N.J.), 2002, Volume: 227, Issue:8 Topics: Animals; Body Weight; Cyclosporine; Dexamethasone; Estradiol; Female; Follicle Stimulating Hormone; Immunocompromised Host; Immunosuppressive Agents; Luteinizing Hormone; Luteoma; Neoplasm Transplantation; Organ Size; Ovarian Neoplasms; Ovariectomy; Ovary; Prolactin; Rats; Rats, Sprague-Dawley; Spleen; Thymus Gland; Transplantation, Heterotopic	2002
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. Cancer research, 2002, Oct-15, Volume: 62, Issue:20 Topics: Animals; Antibodies, Bispecific; CD3 Complex; CD8-Positive T-Lymphocytes; Cyclic AMP; Cyclosporine; Cytotoxicity, Immunologic; Female; Humans; Immunotherapy, Adoptive; Intercellular Adhesion Molecule-1; Killer Cells, Natural; Luminescent Measurements; Lymphocyte Function-Associated Antigen-1; Lymphoma, B-Cell; Membrane Glycoproteins; Mice; Ovarian Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Receptor, ErbB-2; Tacrolimus; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2002
Induction of resistance to Aplidin in a human ovarian cancer cell line related to MDR expression. Cancer biology & therapy, 2005, Volume: 4, Issue:12 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cyclosporine; Depsipeptides; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Genes, MDR; Humans; Isoquinolines; Ovarian Neoplasms; Peptides, Cyclic	2005
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:2 Topics: Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carrier Proteins; Cyclosporine; Cyclosporins; Drug Resistance; Female; Humans; KB Cells; Killer Cells, Natural; Leukemia, Myeloid; Lymphocytes; Membrane Glycoproteins; Monocytes; Neoplasm Proteins; Ovarian Neoplasms; Protein Binding; Tacrolimus; Tumor Cells, Cultured; Verapamil	1994
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours. British journal of cancer, 1994, Volume: 70, Issue:1 Topics: Antineoplastic Agents; Child; Cyclosporine; Cyclosporins; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fluorometry; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine	1994
Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy. Cancer, 1993, Jun-15, Volume: 71, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cyclosporine; Cystadenocarcinoma; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubular Necrosis, Acute; Kidney Tubules; Middle Aged; Ovarian Neoplasms	1993
[Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo]. Zhonghua fu chan ke za zhi, 1996, Volume: 31, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclosporine; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Tumor Cells, Cultured	1996
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines. Anti-cancer drugs, 1995, Volume: 6, Issue:5 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil	1995
[The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma]. Zhonghua fu chan ke za zhi, 1997, Volume: 32, Issue:8 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Genes, MDR; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Random Allocation; Tumor Cells, Cultured; Vincristine	1997
Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies. Neoplasia (New York, N.Y.), 1999, Volume: 1, Issue:2 Topics: Choriocarcinoma; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Female; Genital Neoplasms, Female; Humans; Immunosuppressive Agents; Middle Aged; Ovarian Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms	1999
The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin. Gynecologic oncology, 1992, Volume: 47, Issue:1 Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Death; Cisplatin; Cycloheximide; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance; Emetine; Female; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil	1992
A sequential immunosuppressive treatment with mizoribin (Bredinin) plus cyclosporin A on the subrenal capsule assay. The Kurume medical journal, 1991, Volume: 38, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Administration Schedule; Female; Immunosuppressive Agents; Mice; Ovarian Neoplasms; Rats; Ribonucleosides; Subrenal Capsule Assay	1991